Objective: The aim of the study was to retrospectively evaluate the effect of directional deep brain stimulation (DBS) on ataxia in an essential tremor patient population. Materials and Methods: A retrospective chart review of documented Scale for Assessment and Rating of Ataxia (SARA) scores were analyzed using a case-control design. All subjects we evaluated were treated at a single, tertiary care academic center. We reviewed 14 patients who underwent bilateral ventral intermediate nucleus of the thalamus (VIM) implantation with microelectrode recording, with electrodeposition and segmented contact orientation confirmed via postoperative computed tomography. The main outcome was to determine change in ataxia scores between directional versus monopolar circumferential stimulation. Results: Fourteen patients (9 males, median age at implantation 69 [range 63–82]) underwent surgery between October 2017 and July 2020 at the UNC Movement Disorders Center. SARA scores between directional stimulation and monopolar circumferential stimulation demonstrated a significant reduction in total scores with best possible segmented stimulation (n = 13, p < 0.0001, 95% confidence interval [CI] −3.496 to −6.789). This difference remained statistically significant even after removing the SARA tremor subscore (n = 13, p < 0.0001, 95% CI −3.155 to −6.274). In line with prior reports, SARA score changes from the preoperative state were generally worsened when applying monopolar circumferential stimulation bilaterally (n = 13, p = 0.655; 95% CI −2.836 to 4.359), but improved with directional stimulation (n = 13, p = 0.010; 95% CI −1.216 to −7.547). Conclusion: This retrospective analysis appears to show evidence for improved outcomes through directional stimulation in bilateral VIM DBS implantation with reduction of ataxic side effects that have traditionally plagued postoperative results, all while providing optimized tremor reduction via stimulation.

1.
Lee
D
,
Gan
SR
,
Faust
PL
,
Louis
ED
,
Kuo
SH
.
Climbing fiber-Purkinje cell synaptic pathology across essential tremor subtypes
.
Parkinsonism Relat Disord
.
2018
;
51
:
24
9
. .
2.
Louis
ED
,
Kerridge
CA
,
Chatterjee
D
,
Martuscello
RT
,
Diaz
DT
,
Koeppen
AH
,
Contextualizing the pathology in the essential tremor cerebellar cortex: a patholog-omics approach
.
Acta Neuropathol
.
2019
;
138
(
5
):
859
.
3.
Louis
ED
,
Kuo
SH
,
Tate
WJ
,
Kelly
GC
,
Faust
PL
.
Cerebellar pathology in childhood onset versus adult-onset essential tremor
.
Neurosci Lett
.
2017
;
659
:
69
74
.
4.
Louis
ED
,
Kuo
SH
,
Wang
J
,
Tate
WJ
,
Pan
MK
,
Kelly
GC
,
Cerebellar pathology in familial versus sporadic essential tremor
.
Cerebellum
.
2017
;
16
(
4
):
786
91
. .
5.
Chiu
SY
,
Nozile-Firth
K
,
Klassen
BT
,
Adams
A
,
Lee
K
,
Van Gompel
JJ
,
Ataxia and tolerance after thalamic deep brain stimulation for essential tremor
.
Parkinsonism Relat Disord
.
2020
;
80
:
47
53
. .
6.
Roque
D
.
Segmented versus nonsegmented deep-brain stimulation for essential tremor differ in ataxic side effects
.
Tremor Other Hyperkinet Mov
.
2019
.
7.
Fasano
A
,
Herzog
J
,
Raethjen
J
,
Rose
FE
,
Muthuraman
M
,
Volkmann
J
,
Gait ataxia in essential tremor is differentially modulated by thalamic stimulation
.
Brain
.
2010
;
133
:
3635
48
. .
8.
Bruno
S
,
Nikolov
P
,
Hartmann
CJ
,
Trenado
C
,
Slotty
PJ
,
Vesper
J
,
Directional deep brain stimulation of the thalamic ventral intermediate area for essential tremor increases therapeutic window
.
Neuromodulation
.
2020
;
24
(
2
):
343
.
9.
Pahwa
R
,
Lyons
KE
,
Wilkinson
SB
,
Simpson
RK
 Jr
,
Ondo
WG
,
Tarsy
D
,
Long-term evaluation of deep brain stimulation of the thalamus
.
J Neurosurg
.
2006
;
104
(
4
):
506
12
. .
10.
Shao
MM
,
Liss
A
,
Park
YL
,
DiMarzio
M
,
Prusik
J
,
Hobson
E
,
Early experience with new generation deep brain stimulation leads in Parkinson’s disease and essential tremor patients
.
Neuromodulation
.
2020
;
23
(
4
):
537
.
11.
Fasano
A
,
Helmich
RC
.
Tremor habituation to deep brain stimulation: underlying mechanisms and solutions
.
Mov Disord
.
2019
;
34
(
12
):
1761
.
12.
Al-Fatty
B
,
Ewert
S
,
Kubler
D
,
Kroneberg
D
,
Horn
A
,
Kuhn
AA
.
Connectivity profile of thalamic deep brain stimulation to effectively treat essential tremor
.
Brain
.
2019
.
13.
Oyama
G
,
Thompson
A
,
Foote
KD
,
Limotai
N
,
Abd-El-Barr
M
,
Maling
N
,
Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues
.
Tremor Other Hyperkinet Mov
.
2014
;
4
:
228
. .
14.
Reich
MM
,
Brumberg
J
,
Pozzi
NG
,
Marotta
G
,
Roothans
J
,
Åström
M
,
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?
Brain
.
2016
;
139
:
2948
56
. .
15.
Kuo
SH
,
Lin
CY
,
Wang
J
,
Liou
JY
,
Pan
MK
,
Louis
RJ
,
Deep brain stimulation and climbing fiber synaptic pathology in essential tremor
.
Ann Neurol
.
2016
;
80
(
3
):
461
5
. .
16.
Pollo
C
,
Kaelin-Lang
A
,
Oertel
MF
,
Stieglitz
L
,
Taub
E
,
Fuhr
P
,
Directional deep brain stimulation: an intraoperative double-blind pilot study
.
Brain
.
2014
;
137
:
2015
26
. .
17.
Rebelo
P
,
Green
AL
,
Aziz
TZ
,
Kent
A
,
Schafer
D
,
Venkatesan
L
,
Thalamic directional deep brain stimulation for tremor: spend less, get more
.
Brain Stimul
.
2018
;
11
:
600
6
. .
18.
Choe
CU
,
Hidding
U
,
Schaper
M
,
Gulberti
A
,
Köppen
J
,
Buhmann
C
,
Thalamic short pulse stimulation diminishes adverse effects in essential tremor patients
.
Neurology
.
2018
;
91
(
8
):
e704
e13
. .
19.
Groppa
S
,
Herzog
J
,
Falk
D
,
Riedel
C
,
Deuschl
G
,
Volkmann
J
.
Physiological and anatomical decomposition of subthalamic neurostimulation effects in essential tremor
.
Brain
.
2014
;
137
:
109
21
. .
20.
Biazabal-Carvallo
JF
,
Kagnoff
MN
,
Jimenez-Shahed
J
,
Fekete
R
,
Jankovic
J
.
The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond
.
J Neurol Neurosurg Psychiatry
.
2014
;
85
:
567
72
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.